Axikin Pharmaceuticals

Axikin Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on the development and commercialization of small molecule therapies for severe respiratory, inflammatory, and autoimmune diseases, such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory skin conditions, inflammatory bowel disease, and rheumatoid arthritis. Axikin was spun off from Actimis Pharmaceuticals in June 2008.